A Literature Review of the Potential Diagnostic Biomarkers of Head and Neck Neoplasms

by Heleen Konings, Sofie Stappers, Margot Geens, Benedicte Y. De Winter, Kevin Lamote, Kevin Lamote, Kevin Lamote, Jan P. van Meerbeeck, Jan P. van Meerbeeck, Jan P. van Meerbeeck, Pol Specenier, Pol Specenier, Olivier M. Vanderveken, Olivier M. Vanderveken, Olivier M. Vanderveken, Kristien J. Ledeganck
Published 2020-06-01

In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53

by Jolien Van denBossche, Christophe Deben, Ines De Pauw, Hilde Lambrechts, Christophe Hermans, Vanessa Deschoolmeester, Julie Jacobs, Pol Specenier, Patrick Pauwels, Jan Baptist Vermorken, Marc Peeters, Filip Lardon, An Wouters
Published 2019-05-01

Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy.

by Margot Geens, Sofie Stappers, Heleen Konings, Benedicte Y De Winter, Pol Specenier, Jan P Van Meerbeeck, Gert A Verpooten, Steven Abrams, Annelies Janssens, Marc Peeters, Paul Van de Heyning, Olivier M Vanderveken, Kristien J Ledeganck
Published 2021-01-01

Study protocol for a randomized controlled trial: prophylactic swallowing exercises in head-and-neck cancer patients treated with (chemo)radiotherapy (PRESTO trial)

by Margot Baudelet, Leen Van den Steen, Fréderic Duprez, Marc De Bodt, Sarah Deschuymer, Ann Goeleven, Isabel Hutsebaut, Steven Mariën, Sabine Meersschout, Daan Nevens, Sandra Nuyts, Marc Peeters, Pol Specenier, Michiel Van den Brekel, Lisette van der Molen, Caroline Vandenbruaene, Olivier Vanderveken, Joost Van Dinther, Carl Van Laer, Tom Vauterin, Hilde Verstraete, Gwen Van Nuffelen, Member of the Belgian PRESTO Group
Published 2020-03-01